Literature DB >> 26620534

Pulmonary IgG4-related disease and colon adenocarcinoma: possible paraneoplastic syndrome.

Megan L Krause1, Eunhee S Yi2, Kenneth J Warrington1.   

Abstract

Malignancy has a complicated association with immunoglobulin G4-related disease (IgG4-RD) both being an item in the differential diagnosis as well as malignancy occurring in the background of IgG4-RD in the same organ. However, recently there is evidence of higher rates of distant malignancy in patients with IgG4-RD. Here we report a case of pulmonary IgG4-RD potentially consistent with a paraneoplastic phenomenon which improved with treatment of the underlying colon adenocarcinoma.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  immunoglobulin G; interstitial lung diseases; paraneoplastic syndromes

Mesh:

Substances:

Year:  2015        PMID: 26620534     DOI: 10.1111/1756-185X.12806

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  3 in total

1.  An initial exploration for comprehensive assessment of IgG4-related lung disease: analyses on the cases enrolled from a systematic review.

Authors:  An Wang; Jie Fan; Xiaofeng Chen; Shaohua Wang
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Progression of immunoglobulin G4-related disease to systematic lupus erythematosus after gastric cancer surgery: A case report.

Authors:  Haruna Arai; Hiroki Hayashi; Soshiro Ogata; Kenichi Uto; Jun Saegusa; Kazuo Takahashi; Shigehisa Koide; Daijyo Inaguma; Midori Hasegawa; Yukio Yuzawa
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

3.  Long-term spontaneous remission with active surveillance in IgG4-related pleuritis: A case report and literature review.

Authors:  Go Makimoto; Kadoaki Ohashi; Kohei Taniguchi; Junichi Soh; Akihiko Taniguchi; Nobuaki Miyahara; Shinichi Toyooka; Tadashi Yoshino; Yoshinobu Maeda; Katsuyuki Kiura
Journal:  Respir Med Case Rep       Date:  2019-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.